Vaccine Manufacturers
-
{
- All
- News
- Videos
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
JP Nadda Launches Indigenously Manufactured Tetanus And Adult Diphtheria Vaccine At Central Research Institute
Union Minister for Health and Family Welfare J. P. Nadda on Saturday launched the indigenously manufactured tetanus and adult diphtheria (Td) vaccine at the Central Research Institute (CRI) here in Himachal Pradesh.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine
Vaccine manufacturer Indian Immunologicals Limited (IIL) signed a Memorandum of Association (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of the Zika vaccine.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
Billionaire Cyrus Poonawalla Suffers Cardiac Arrest, Stable After Angioplasty
Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.
-
India Plans $2 Billion In Incentives For New Manufacturing Sectors: Report
India is planning to offer incentives of up to Rs 18,000 Crore ($2.2 billion) to spur local manufacturing in six new sectors including chemicals, shipping containers and inputs for vaccines, two government officials said.
-
Indian Immunologicals Targets Dengue Vaccine Launch By January 2026
Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country's first such vaccine heats up.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
JP Nadda Launches Indigenously Manufactured Tetanus And Adult Diphtheria Vaccine At Central Research Institute
Union Minister for Health and Family Welfare J. P. Nadda on Saturday launched the indigenously manufactured tetanus and adult diphtheria (Td) vaccine at the Central Research Institute (CRI) here in Himachal Pradesh.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine
Vaccine manufacturer Indian Immunologicals Limited (IIL) signed a Memorandum of Association (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of the Zika vaccine.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
Billionaire Cyrus Poonawalla Suffers Cardiac Arrest, Stable After Angioplasty
Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.
-
India Plans $2 Billion In Incentives For New Manufacturing Sectors: Report
India is planning to offer incentives of up to Rs 18,000 Crore ($2.2 billion) to spur local manufacturing in six new sectors including chemicals, shipping containers and inputs for vaccines, two government officials said.
-
Indian Immunologicals Targets Dengue Vaccine Launch By January 2026
Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country's first such vaccine heats up.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
